Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
3,331.35
40.3 (1.22%)
BSENSE

Nov 20

BSE+NSE Vol: 3.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,331.35",
    "chg": 40.3,
    "chgp": "1.22%",
    "dir": 1,
    "prev_price": "3,291.05",
    "mcapval": "54,433.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE068V01023",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.17 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Ltd is Rated Buy by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gland-pharma-ltd-is-rated-buy-by-marketsmojo-4270026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_mojoScore_4270026.png",
        "date": "2026-11-21 10:10:33",
        "description": "Gland Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 09 Nov 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 21 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 3428",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-of-rs-3428-4263759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_priceRelatedfactors_4263759.png",
        "date": "2026-11-16 10:09:01",
        "description": "Surging to an intraday peak of Rs 3428 on 16 Nov 2026, Gland Pharma Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps an impressive rally that has seen the stock more than double from its 52-week low of Rs 1575, reflecting robust momentum underpinned by a confluence of technical indicators and sustained price strength."
      },
      {
        "title": "Gland Pharma Gains 5.22%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-gains-522-4-key-factors-driving-the-weeks-momentum-4261619",
        "imagepath": "",
        "date": "2026-11-14 12:00:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> New 52-week high at Rs.3,356</p>\n                    <p><strong>Nov 09:</strong> Intraday surge of 7.02%</p>\n                    <p><strong>Nov 09:</strong> Mojo Grade upgraded to Buy</p>\n                    <p><strong>Nov 11:</strong> Technical momentum strengthens with bullish signals</p>\n                    <p><strong>Nov 13:</strong> Week closes at Rs.3,334.70 (+5.22%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,169.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"sta..."
      },
      {
        "title": "Gland Pharma Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gland-pharma-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4257183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_mojoScore_4257183.png",
        "date": "2026-11-10 08:52:07",
        "description": "Gland Pharma Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial performance, valuation metrics, and overall quality assessment. The upgrade, effective from 09 Nov 2026, is underpinned by a comprehensive analysis of the company’s recent quarterly results, market-beating returns, and bullish technical trends, signalling renewed investor confidence in this small-cap pharmaceutical player."
      },
      {
        "title": "Gland Pharma Ltd Surges 7.02% to Day's High of Rs 3356 — Outperforms Sector by 5.29 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-ltd-hits-intraday-high-with-702-surge-on-9-nov-2026-4256855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_priceRelatedfactors_4256855.png",
        "date": "2026-11-09 10:21:58",
        "description": "The Sensex declined by 0.22% on 09 Nov 2026, while Gland Pharma Ltd surged 7.02%, touching an intraday high of Rs 3356. This 5.29-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 3356",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs3356-4256500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_priceRelatedfactors_4256500.png",
        "date": "2026-11-09 09:51:11",
        "description": "Surging past its previous peak, Gland Pharma Ltd touched a new 52-week high of Rs 3356 on 09 Nov 2026, marking a remarkable 78.34% gain over the past year. This rally stands in stark contrast to the Sensex’s decline of 2.80% during the same period, underscoring the stock’s strong momentum amid a mixed market backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 3183.85",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-at-rs318385-4252246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_priceRelatedfactors_4252246.png",
        "date": "2026-11-05 10:17:52",
        "description": "With a 66.08% gain over the past year, Gland Pharma Ltd has surged to a new 52-week high of Rs 3183.85 on 5 Nov 2026, significantly outperforming the Sensex which declined 5.57% over the same period. This milestone reflects a powerful technical momentum that has propelled the stock well above all key moving averages, signalling robust price strength in the pharmaceuticals sector."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 3171",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-ltd-hits-new-52-week-high-marking-significant-milestone-4250868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GlandPharmaLtd_priceRelatedfactors_4250868.png",
        "date": "2026-11-04 13:11:40",
        "description": "With a remarkable 65.55% gain over the past year, Gland Pharma Ltd has surged to a fresh 52-week high of Rs 3,171, closing just 0.03% shy of this milestone on 4 Nov 2026. This rally stands in stark contrast to the Sensex’s 7.71% decline over the same period, underscoring the stock’s strong momentum amid a mixed market backdrop."
      },
      {
        "title": "Gland Pharma Gains 9.63%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gland-pharma-gains-963-3-key-factors-driving-the-weeks-momentum-4245659",
        "imagepath": "",
        "date": "2026-10-31 13:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at ₹2,843.90, modest gain of 0.66%</p>\n                    <p><strong>27 Oct:</strong> Technical momentum shifts signal bullish outlook, stock surges 4.14% to ₹2,961.55</p>\n                    <p><strong>28 Oct:</strong> Valuation shifts to very expensive, Mojo Grade upgraded to Buy</p>\n                    <p><strong>29 Oct:</strong> Continued gains with 0.90% rise amid mixed technical signals</p>\n                    <p><strong>30 Oct:</strong> Week closes at ₹3,097.50, total weekly gain of 9.63%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label..."
      }
    ],
    "total": 89,
    "sid": "1003443",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "20-Nov-2026",
      "details": "Appointment of Mr. Ajay Sahni as the President of Phixen SAS(wholly owned step down subsidiary of Gland Pharma Limited) with effect from November 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Nov-2026",
      "details": "Schedule of Investor Meet Intimation",
      "source": "BSE"
    },
    {
      "caption": "Grant Of Options To Purchase Securities",
      "datetime": "16-Nov-2026",
      "details": "Grant of Options to Purchase Securities",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>2000%</strong> dividend, ex-date: 11 Aug 26",
          "dt": "2026-08-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Change in Management

20-Nov-2026 | Source : BSE

Appointment of Mr. Ajay Sahni as the President of Phixen SAS(wholly owned step down subsidiary of Gland Pharma Limited) with effect from November 30 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Nov-2026 | Source : BSE

Schedule of Investor Meet Intimation

Grant Of Options To Purchase Securities

16-Nov-2026 | Source : BSE

Grant of Options to Purchase Securities

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Gland Pharma Ltd has declared 2000% dividend, ex-date: 11 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available